Skip to main content
. 2019 May 31;7:e6983. doi: 10.7717/peerj.6983

Table 2. CellCycler simulation results.

Simulation results in terms of diameter loss for the drugs as monotherapy and in combination.

Drug schedule Diameter loss
Taxol
Day 1 weekly 0.57 mm
EGFRi
Days 1–5 every week 0.90 mm
Taxol + EGFRi
Taxol (Day 1) + EGFRi (Days 1–5) weekly 1.38 mm
Taxol ->EGFRi:
Taxol (Day 1) + EGFRi (Days 2–6) weekly 1.44 mm
EGFRi ->Taxol:
EGFRi (Days 1–5) + Taxol (Day 6) weekly 1.31 mm